213 related articles for article (PubMed ID: 15751073)
21. Rosiglitazone modulates pigeon atherosclerotic lipid accumulation and gene expression in vitro.
Anderson JL; Keeley MC; Smith SC; Smith EC; Taylor RL
Poult Sci; 2014 Jun; 93(6):1368-74. PubMed ID: 24879686
[TBL] [Abstract][Full Text] [Related]
22. Upregulation of IL-1 Receptor Antagonist by Aspirin in Glial Cells via Peroxisome Proliferator-Activated Receptor-Alpha.
Chakrabarti S; Prorok T; Roy A; Patel D; Dasarathi S; Pahan K
J Alzheimers Dis Rep; 2021; 5(1):647-661. PubMed ID: 34632302
[TBL] [Abstract][Full Text] [Related]
23. Multiple gene-drug prediction tool reveals Rosiglitazone based treatment pathway for non-segmental vitiligo.
Zhao S; Chen X; Dutta K; Chen J; Wang J; Zhang Q; Jia H; Sun J; Lai Y
Inflammation; 2024 Apr; 47(2):678-695. PubMed ID: 38159176
[TBL] [Abstract][Full Text] [Related]
24. VSP-2 attenuates secretion of inflammatory cytokines induced by LPS in BV2 cells by mediating the PPARγ
Cui J; Xu L; Sun Y; Dai L; Mo Y; Yun K; Chen Y; Chen L
Open Life Sci; 2024; 19(1):20220861. PubMed ID: 38681727
[TBL] [Abstract][Full Text] [Related]
25. Rapid brain penetration of interleukin-1 receptor antagonist in rat cerebral ischaemia: pharmacokinetics, distribution, protection.
Greenhalgh AD; Galea J; Dénes A; Tyrrell PJ; Rothwell NJ
Br J Pharmacol; 2010 May; 160(1):153-9. PubMed ID: 20412072
[TBL] [Abstract][Full Text] [Related]
26. PPARγ is a nexus controlling alternative activation of macrophages via glutamine metabolism.
Nelson VL; Nguyen HCB; Garcìa-Cañaveras JC; Briggs ER; Ho WY; DiSpirito JR; Marinis JM; Hill DA; Lazar MA
Genes Dev; 2018 Aug; 32(15-16):1035-1044. PubMed ID: 30006480
[TBL] [Abstract][Full Text] [Related]
27. PPAR- γ impairment alters peroxisome functionality in primary astrocyte cell cultures.
Di Cesare Mannelli L; Zanardelli M; Micheli L; Ghelardini C
Biomed Res Int; 2014; 2014():546453. PubMed ID: 24729976
[TBL] [Abstract][Full Text] [Related]
28. Harnessing peroxisome proliferator-activated receptor γ agonists to induce Heme Oxygenase-1: a promising approach for pulmonary inflammatory disorders.
Lee IT; Yang CC; Yang CM
Cell Commun Signal; 2024 Feb; 22(1):125. PubMed ID: 38360670
[TBL] [Abstract][Full Text] [Related]
29. PPAR beta/delta regulates the immune response mechanisms in the porcine endometrium during LPS-induced inflammation - An in vitro study.
Golubska M; Paukszto Ł; Kurzyńska A; Mierzejewski K; Gerwel Z; Bogacka I
Theriogenology; 2024 Jun; 226():130-140. PubMed ID: 38878465
[TBL] [Abstract][Full Text] [Related]
30. Synthesis of a new 2-prenylated quinoline as potential drug for metabolic syndrome with pan-PPAR activity and anti-inflammatory effects.
Villarroel-Vicente C; García A; Zibar K; Schiel MA; Ferri J; Hennuyer N; Enriz RD; Staels B; Cortes D; Cabedo N
Bioorg Med Chem Lett; 2024 Jul; 106():129770. PubMed ID: 38677560
[TBL] [Abstract][Full Text] [Related]
31. Rosiglitazone increases dendritic spine density and rescues spine loss caused by apolipoprotein E4 in primary cortical neurons.
Brodbeck J; Balestra ME; Saunders AM; Roses AD; Mahley RW; Huang Y
Proc Natl Acad Sci U S A; 2008 Jan; 105(4):1343-6. PubMed ID: 18212130
[TBL] [Abstract][Full Text] [Related]
32. In vitro Screening and Evaluation of 37 Traditional Chinese Medicines for Their Potential to Activate Peroxisome Proliferator-Activated Receptors-γ.
Gao D; Zhang Y; Yang F; Lin Y; Zhang Q; Xia Z
Pharmacogn Mag; 2016; 12(46):120-7. PubMed ID: 27076748
[TBL] [Abstract][Full Text] [Related]
33. Interleukin-1 Receptor Antagonist as Therapy for Traumatic Brain Injury.
Lindblad C; Rostami E; Helmy A
Neurotherapeutics; 2023 Oct; 20(6):1508-1528. PubMed ID: 37610701
[TBL] [Abstract][Full Text] [Related]
34. The precursor form of IL-1alpha is an intracrine proinflammatory activator of transcription.
Werman A; Werman-Venkert R; White R; Lee JK; Werman B; Krelin Y; Voronov E; Dinarello CA; Apte RN
Proc Natl Acad Sci U S A; 2004 Feb; 101(8):2434-9. PubMed ID: 14983027
[TBL] [Abstract][Full Text] [Related]
35. Sustained intra-cartilage delivery of interleukin-1 receptor antagonist using cationic peptide and protein-based carriers.
Mehta S; Boyer TL; Akhtar S; He T; Zhang C; Vedadghavami A; Bajpayee AG
Osteoarthritis Cartilage; 2023 Jun; 31(6):780-792. PubMed ID: 36739939
[TBL] [Abstract][Full Text] [Related]
36. Modulation of PPARγ provides new insights in a stress induced premature senescence model.
Briganti S; Flori E; Bellei B; Picardo M
PLoS One; 2014; 9(8):e104045. PubMed ID: 25101957
[TBL] [Abstract][Full Text] [Related]
37. IL-1RA injected intra-cisterna magna confers extended prophylaxis against lipopolysaccharide-induced neuroinflammatory and sickness responses.
Frank MG; Barrientos RM; Thompson BM; Weber MD; Watkins LR; Maier SF
J Neuroimmunol; 2012 Nov; 252(1-2):33-9. PubMed ID: 22871632
[TBL] [Abstract][Full Text] [Related]
38. Selective deletion of PPARβ/δ in fibroblasts causes dermal fibrosis by attenuated LRG1 expression.
Sng MK; Chan JSK; Teo Z; Phua T; Tan EHP; Wee JWK; Koh NJN; Tan CK; Chen JP; Pal M; Tong BMK; Tnay YL; Ng XR; Zhu P; Chiba S; Wang X; Wahli W; Tan NS
Cell Discov; 2018; 4():15. PubMed ID: 29619245
[TBL] [Abstract][Full Text] [Related]
39. Rosiglitazone Promotes Microglial Distribution via Activation of PPARγ and CD36 in the ICH Rat Model.
Mu Q; He Q; Zhou H; Xu Y; Wu G
Neuro Endocrinol Lett; 2024 Apr; 45(2):96-106. PubMed ID: 38583188
[TBL] [Abstract][Full Text] [Related]
40. Exploring the mechanism of enterotoxicity mediated by the microbiome-butyrate-PPAR axis in podophyllotoxin through the toxicological evidence chain (TEC) concept.
Duan J; Du P; Jiang T; Ma X; Sun J; Liang J; Wang J; Liu C
Ecotoxicol Environ Saf; 2024 Jul; 280():116548. PubMed ID: 38850705
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
